GoogleAnalytics
Go
View All
FIGURE NET JEJUNUM and ILEUM-SURVIVAL, PATHOLOGICAL
FIGURE NET JEJUNUM and ILEUM-T1
FIGURE NET JEJUNUM and ILEUM-T2
FIGURE NET JEJUNUM and ILEUM-T3
FIGURE NET JEJUNUM and ILEUM-T4
FIGURE NET PANCREAS-ANATOMY
FIGURE NET PANCREAS-N1
FIGURE NET PANCREAS-NODAL MAP
FIGURE NET PANCREAS-SURVIVAL, PATHOLOGICAL
FIGURE NET PANCREAS-T1, T2
FIGURE NET PANCREAS-T3
FIGURE NET PANCREAS-T4
FIGURE NET STOMACH-ANATOMY
FIGURE NET STOMACH-N1
FIGURE NET STOMACH-NODAL MAP
FIGURE NET STOMACH-SURVIVAL, CLINICAL
FIGURE NET STOMACH-T1
FIGURE NET STOMACH-T2
FIGURE NET STOMACH-T3
FIGURE NET STOMACH-T4
Five-year overall survival of 2,013 patients with MCC in the NCDB with clinical staging only for local disease (cN0 pNx; i
Five-year overall survival of 2,465 MCC patients with regional lymph node metastases in the NCDB, stratified by tumor burden and primary tumor status: clinically and radiologically occult nodal metastasis (N1a) detected by SLNB or otherwise; clinically or radiologically detected and pathologically confirmed nodal metastasis (N1b) with or without the presence of a primary tumor; and in-transit disease (N2)
Five-year overall survival of 5,371 patients with MCC in the NCDB with pathological staging, including 1,502 patients in stage group I, 493 in stage group IIA, 127 in stage group IIB, 1,536 in stage group IIIA, 929 in stage group IIIB, and 784 in stage group IV
Five-year overall survival of 6,127 patients with local MCC only (clinically and, if known, pathologically node negative) in the NCDB, stratified by T category ( 2 cm, T1; 2 cm, T2/3; involving fascia, muscle, cartilage, or bone, T4)
Five-year overall survival of 9,387 patients with MCC in the NCDB, stratified by local, regional nodal, and distant metastatic disease
Flexner-Wintersteiner rosettes
Fludarabine
Fluid attenuated inversion recovery (FLAIR)
Fluorescence in situ hybridization (FISH)
Refresh
firstprev
...11121314151617181920...
30select
nextlast
Displaying items 451 - 480 of 1114